North America Leads the Short Bowel Syndrome Market Amid Advanced Healthcare Infrastructure
North America has established itself as the dominant region in the global Short Bowel Syndrome Market, driven by advanced healthcare infrastructure, high awareness of gastrointestinal disorders, and significant investment in research and development. The region accounted for approximately USD 2.5 billion in 2024 and is projected to reach USD 5.1 billion by 2035. The region's leadership reflects...
0 Σχόλια 0 Μοιράστηκε 3 Views 0 Προεπισκόπηση